LeMaitre Vascular, Inc. (LMAT) — Fair Value Analysis

Base-case fair value (P50): $89.42 · Current price: $109.61 · Verdict: Overvalued

The Verdict on LMAT

LEMAITRE VASCULAR INC (LMAT) is currently trading at $109.61. Our Monte Carlo simulations, which model thousands of future scenarios, suggest a median fair value (P50) of $89.42. This indicates the stock is trading 18.4% above its intrinsic value based on our models' central estimate. Despite this discrepancy between current price and median fair value, our overall verdict for LMAT remains "Fairly Valued," acknowledging the probabilistic range of outcomes rather than a singular price target. This assessment accounts for both potential downside scenarios and more optimistic bull cases without committing to extreme valuations.

How LMAT stacks up against peers

LMAT's operational and financial health, relative to its sector peers, is classified as "average." This "average" quality tier suggests that the company is performing in line with its industry, neither significantly outperforming nor underperforming its competitors. While the market currently prices LMAT at $109.61, this "average" standing implies that the 18.4% premium over our P50 of $89.42 may not be readily justified by superior fundamental metrics or competitive advantages compared to the broader sector.

What this means for investors

For investors evaluating LMAT, the current price of $109.61 trades at a notable premium when compared to our Monte Carlo-derived median fair value of $89.42, representing an 18.4% difference. Although our comprehensive verdict is "Fairly Valued," this reflects a balance across the full distribution of potential outcomes, encompassing both downside and upside scenarios. The company's "average" quality tier further underscores that, while fundamentally sound, LMAT doesn't present an obvious compelling value proposition at its current market valuation relative to its peers. The FairCurve platform offers a more detailed understanding of these probabilistic valuations. Sign up for a free FairCurve account to see the full bear/bull distribution and track LMAT's fair value as new fundamentals are released.